Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Healthcare Biotechnology
Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Who pulls the plug just prior to an FDA decision ?
View:
Post by GoBBs on Jan 27, 2021 7:45pm

Who pulls the plug just prior to an FDA decision ?

More to this story I sense ....

If they were expecting approval they would indicate they are anxiously awaiting approval....and if you were expecting approval wouldn't you wait to say its for sale AFTER its approved. What a laugh.
Comment by eric40 on Jan 27, 2021 9:40pm
This managment are criminals that's all there is to say.
Comment by eric40 on Jan 27, 2021 10:05pm
It reminds me what they did with IVIG 2 years ago. Wash/rinse /repeat. They got away with it ruining thousands of investors and they do the same now. Except it is even worst now since Ryplazim has a PDUFA date of june 5 2021 in less than 4 months. And they resubmit the BLA helped with external expert so obviously RYPLAZIM SHOULD BE APPROVED BY JUNE 5 WITHIN THE NEXT FOR MONTHS! They already know ...more  
Comment by GoBBs on Jan 27, 2021 10:15pm
Its clearly slight of hand and appears they are merely trying to make it look bad so retail sells and they scoop up the suckers cheap shares. Lovely.
Liminal BioSciences Inc.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities